158 related articles for article (PubMed ID: 9596614)
1. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
Lee D
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
[No Abstract] [Full Text] [Related]
2. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
Craig JS; McClure BG; Tubman TR
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
[No Abstract] [Full Text] [Related]
3. Preventing RhD haemolytic disease of the newborn.
van Dijk B
BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
[No Abstract] [Full Text] [Related]
4. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
Harding K
Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
[No Abstract] [Full Text] [Related]
5. RhD hemolytic disease of the newborn.
Bowman JM
N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
[No Abstract] [Full Text] [Related]
6. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
7. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
Contreras M
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
[No Abstract] [Full Text] [Related]
8. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
9. Current status of immunoprophylaxis with anti-D immunoglobin.
Engelfriet CP; Reesink HW; Judd WJ; Ulander VM; Kuosmanen M; Koskinen S; Rouger P; Morelati F; Tantalo V; Fujii T; de Haas M; van der Schoot CE; Overbeeke M; Koelewijn J; Bonsel G; Vrijkotte T; Zupańska B; Martin-Vega C; Parra Lopez R; de Silva M; Contreras M; Panzer S; Ulm B; Mayr WR
Vox Sang; 2003 Nov; 85(4):328-37. PubMed ID: 14633261
[No Abstract] [Full Text] [Related]
10. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
Urbaniak SJ
Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
[No Abstract] [Full Text] [Related]
11. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
Mikhaĭlova AA; Klimova NIa
Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.
Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A
BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771
[TBL] [Abstract][Full Text] [Related]
13. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
14. The prevention and management of haemolytic disease of the newborn.
Contreras M; de Silva M
J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
[No Abstract] [Full Text] [Related]
15. Economics of antenatal prophylaxis.
Cairns JA
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
[No Abstract] [Full Text] [Related]
16. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
17. Haemolytic disease of the newborn: the new NICE guidelines.
Thompson J
J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
[TBL] [Abstract][Full Text] [Related]
18. The history of rhesus prophylaxis with anti-D.
Wegmann A; Glück R
Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
[No Abstract] [Full Text] [Related]
19. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
McFadyen IR; Martlew VJ; Howard HL; Clarke CA
BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
[No Abstract] [Full Text] [Related]
20. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
